201 related articles for article (PubMed ID: 15016427)
41. Spongy degeneration of the brain, Canavan disease: biochemical and molecular findings.
Matalon RM; Michals-Matalon K
Front Biosci; 2000 Mar; 5():D307-11. PubMed ID: 10704428
[TBL] [Abstract][Full Text] [Related]
42. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease.
Kaul R; Gao GP; Balamurugan K; Matalon R
Nat Genet; 1993 Oct; 5(2):118-23. PubMed ID: 8252036
[TBL] [Abstract][Full Text] [Related]
43. Succinate semialdehyde dehydrogenase deficiency does not down-regulate gamma-hydroxybutyric acid binding sites in the mouse brain.
Mehta AK; Gould GG; Gupta M; Carter LP; Gibson KM; Ticku MK
Mol Genet Metab; 2006 May; 88(1):86-9. PubMed ID: 16406647
[TBL] [Abstract][Full Text] [Related]
44. Clinical, cytogenetic and molecular characterization of a patient with combined succinic semialdehyde dehydrogenase deficiency and incomplete WAGR syndrome with obesity.
Jung R; Rauch A; Salomons GS; Verhoeven NM; Jakobs C; Michael Gibson K; Lachmann E; Sass JO; Trautmann U; Zweier C; Staatz G; Knerr I
Mol Genet Metab; 2006 Jul; 88(3):256-60. PubMed ID: 16545979
[TBL] [Abstract][Full Text] [Related]
45. Vigabatrin improves paroxysmal dystonia in succinic semialdehyde dehydrogenase deficiency.
Leuzzi V; Di Sabato ML; Deodato F; Rizzo C; Boenzi S; Carducci C; Malaspina P; Liberanome C; Dionisi-Vici C
Neurology; 2007 Apr; 68(16):1320-1. PubMed ID: 17438226
[No Abstract] [Full Text] [Related]
46. Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1-/- mice and characterization of gamma-hydroxybutyric acid pharmacology.
Knerr I; Pearl PL; Bottiglieri T; Snead OC; Jakobs C; Gibson KM
J Inherit Metab Dis; 2007 Jun; 30(3):279-94. PubMed ID: 17457693
[TBL] [Abstract][Full Text] [Related]
47. [Succinic semialdehyde dehydrogenase deficiency: decrease in 4-OH-butyric acid levels with low doses of vigabatrin].
Escalera GI; Ferrer I; Marina LC; Sala PR; Salomons GS; Jakobs C; Pérez-Cerdá C
An Pediatr (Barc); 2010 Feb; 72(2):128-32. PubMed ID: 20018576
[TBL] [Abstract][Full Text] [Related]
48. MRI findings in succinic semialdehyde dehydrogenase deficiency.
Yalçinkaya C; Gibson KM; Gündüz E; Koçer N; Fiçicioğlu C; Küçükercan I
Neuropediatrics; 2000 Feb; 31(1):45-6. PubMed ID: 10774997
[No Abstract] [Full Text] [Related]
49. Neuroleptic malignant syndrome in a patient with succinic semialdehyde dehydrogenase deficiency.
Neu P; Seyfert S; Brockmöller J; Dettling M; Marx P
Pharmacopsychiatry; 2002 Jan; 35(1):26-8. PubMed ID: 11819156
[TBL] [Abstract][Full Text] [Related]
50. Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency.
Malaspina P; Picklo MJ; Jakobs C; Snead OC; Gibson KM
Hum Genomics; 2009 Jan; 3(2):106-20. PubMed ID: 19164088
[TBL] [Abstract][Full Text] [Related]
51. [Succinic semialdehyde dehydrogenase deficiency: an inheritable neurometabolic disease].
Gahr M; Connemann BJ; Schönfeldt-Lecuona CJ; Freudenmann RW
Fortschr Neurol Psychiatr; 2013 Mar; 81(3):154-61. PubMed ID: 23516105
[TBL] [Abstract][Full Text] [Related]
52. SSADH deficiency leads to elevated extracellular GABA levels and increased GABAergic neurotransmission in the mouse cerebral cortex.
Drasbek KR; Vardya I; Delenclos M; Gibson KM; Jensen K
J Inherit Metab Dis; 2008 Dec; 31(6):662-8. PubMed ID: 18696252
[TBL] [Abstract][Full Text] [Related]
53. Structure of human succinic semialdehyde dehydrogenase gene: identification of promoter region and alternatively processed isoforms.
Blasi P; Boyl PP; Ledda M; Novelletto A; Gibson KM; Jakobs C; Hogema B; Akaboshi S; Loreni F; Malaspina P
Mol Genet Metab; 2002 Aug; 76(4):348-62. PubMed ID: 12208142
[TBL] [Abstract][Full Text] [Related]
54. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease.
Klugmann M; Leichtlein CB; Symes CW; Serikawa T; Young D; During MJ
Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013
[TBL] [Abstract][Full Text] [Related]
55. Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency.
Akaboshi S; Hogema BM; Novelletto A; Malaspina P; Salomons GS; Maropoulos GD; Jakobs C; Grompe M; Gibson KM
Hum Mutat; 2003 Dec; 22(6):442-50. PubMed ID: 14635103
[TBL] [Abstract][Full Text] [Related]
56. Succinic semialdehyde dehydrogenase from the parasitic cattle tick Rhipicephalus microplus: gene identification, biochemical characterization and comparison with the mouse ortholog.
Rothacker B; Werr M; Ilg T
Mol Biochem Parasitol; 2008 Sep; 161(1):32-43. PubMed ID: 18588919
[TBL] [Abstract][Full Text] [Related]
57. The first case of 4-hydroxybutyric aciduria in Japan.
Ishiguro Y; Kajita M; Aoshima T; Watanabe K; Kimura M; Yamaguchi S
Brain Dev; 2001 Mar; 23(2):128-30. PubMed ID: 11248463
[TBL] [Abstract][Full Text] [Related]
58. Mutation analysis in a patient with succinic semialdehyde dehydrogenase deficiency: a compound heterozygote with 103-121del and 1460T > A of the ALDH5A1 gene.
Aoshima T; Kajita M; Sekido Y; Ishiguro Y; Tsuge I; Kimura M; Yamaguchi S; Watanabe K; Shimokata K; Niwa T
Hum Hered; 2002; 53(1):42-4. PubMed ID: 11901270
[TBL] [Abstract][Full Text] [Related]
59. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.
Matalon R; Michals K; Sebesta D; Deanching M; Gashkoff P; Casanova J
Am J Med Genet; 1988 Feb; 29(2):463-71. PubMed ID: 3354621
[TBL] [Abstract][Full Text] [Related]
60. A boy with a severe phenotype of succinic semialdehyde dehydrogenase deficiency.
Yamakawa Y; Nakazawa T; Ishida A; Saito N; Komatsu M; Matsubara T; Obinata K; Hirose S; Okumura A; Shimizu T
Brain Dev; 2012 Feb; 34(2):107-12. PubMed ID: 21612881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
